Background Trials have evaluated the use of clopidogrel and aspirin to prevent stroke after
an ischemic stroke or transient ischemic attack (TIA). In a previous trial, ticagrelor was not …

Background and Purpose: Among patients with a transient ischemic attack or minor ischemic
strokes, those with ipsilateral atherosclerotic stenosis of cervicocranial vasculature have the …

BACKGROUND AND PURPOSE: Ticagrelor is a novel P2Y12 antagonist, and little is known
about its efficacy and safety in the endovascular treatment of aneurysms. This study …

BACKGROUND Dual antiplatelet therapy (DAPT) associating aspirin+ clopidogrel is
commonly utilized in neurovascular interventions despite unpredictable clopidogrel efficacy …

Transient ischemic attack (TIA) constitutes an important clinical condition, indicating the
presence of considerable risk for a subsequent ischemic stroke. Its prompt diagnosis and …

Importance Results show the short-term risk of hemorrhage in treating patients with acute
transient ischemic attack (TIA) or minor acute ischemic stroke (AIS) with clopidogrel plus …

Importance Dual antiplatelet therapy (DAPT) with ticagrelor and aspirin has been found to
be effective for secondary prevention after minor ischemic stroke or transient ischemic attack …

Significant advances in our understanding of transient ischemic attack (TIA) have taken
place since it was first recognized as a major risk factor for stroke during the late 1950's …

Importance Reduction of subsequent disabling stroke is the main goal of preventive
treatment in the acute setting after transient ischemic attack (TIA) or minor ischemic stroke …

Objective To determine if inclusion/exclusion (I/E) criteria of clinical trial protocols can be
represented as structured queries and executed using a secure federated research platform …